Top Markets
#1 龙虾 (Lobster) 龙虾 (Lobster) +34.74%
#2 Cortex Cortex +32.63%
#3 DexNet DexNet +23.20%
#4 wojak wojak +21.48%
#5 Akedo Akedo +20.54%
#6 Pons Pons +18.91%
#7 SODAX SODAX +17.42%
#8 APEX APEX +13.93%
#9 ETHGas ETHGas +13.11%
#10 OpenEden OpenEden +12.21%
Coin of the day
龙虾 (Lobster) 龙虾 (Lobster)
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
HBM Holdings Limited HBM Holdings Limited

HBM Holdings Limited

2142
Kedudukan dalam Saham #7297
HBM Holdings Limited is a clinical-stage biopharmaceutical enterprise focused... HBM Holdings Limited is a clinical-stage biopharmaceutical enterprise focused on identifying and developing unique antibody-based treatments for a variety of immunological conditions and cancers. The company's pipeline includes several promising assets. In immunology, Batoclimab (HBM9161) is a human monoclonal antibody specifically designed to bind and inhibit the neonatal fragment crystallizable receptor, while Tanfanercept (HBM9036) is under development to address moderate to severe dry eye disease. For oncology, HBM Holdings is advancing various therapies, such as HBM7008, a bispecific antibody targeting tumor-associated antigens, and HBM4003, a human anti-CTLA-4 antibody. Additional cancer candidates in their portfolio include HBM9302 for breast and gastric cancers, HBM7020 for multiple myeloma, and a suite of treatments—HBM1007, HBM1029, HBM7015, HBM7008, and HBM1022—geared towards solid tumors. Furthermore, HBM9022 is being developed to treat SARS-COV-2. Operating globally, HBM Holdings has a presence in Mainland China, the United States, Europe, and other international markets. The company also fosters strategic partnerships for antibody-drug conjugate (ADC) projects with LegoChem Biosciences Inc. and Duality Biotherapeutics, Inc. HBM Holdings Limited was founded in 2016 and is based in Shanghai, People's Republic of China.
Harga Saham
$1.95
Modal Pasaran
$1.64B
Perubahan (1 hari)
-6.69%
Perubahan (1 tahun)
19.42%
Negara
CN
Perdagangan HBM Holdings Limited (2142)

Kategori

Healthcare
Sejarah harga saham bagi HBM Holdings Limited (2142)
Harga penutupan tertinggi: $1.98 pada 2026-08-01

Harga penutupan terendah: $1.35 pada 2020-12-01
Sejarah harga saham HBM Holdings Limited dari 2020 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) -0.89%
2025 894.28%
2024 -16.69%
2023 -21.19%
2022 -75.51%
2021 -21.32%
2020 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.36 39.87%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.06K 50.29%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.48%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $140.81 475.44%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $767.59 8.07%
CH